DLB R&D to Revenue
Dolby Laboratories Common Stock · R&D to Revenue
DLB R&D to Revenue
Latest reported19.40%period ending
DLB FY R&D/Revenue (12.92% → 19.40%)
Latest values, visible window
High-resolution chart · PNG
DLB r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 19.4045% | |
| 20.7002% | |
| 20.8905% | |
| 20.8307% | |
| 19.7962% | |
| 20.5755% | |
| 19.1581% | |
| 22.4534% | |
| 21.5739% | |
| 21.4097% | |
| 20.7414% | |
| 19.0723% | |
| 18.5502% | |
| 15.1299% | |
| 12.9691% | |
| 11.3771% | |
| 9.2717% | |
| 9.6965% | |
| 9.1507% | |
| 9.0353% | |
| 9.3095% | |
| 8.1231% | |
| 8.3974% | |
| 9.3459% | |
| 12.9207% |